PROXY STATEMENT

Company

INTEGRATED BIOPHARMA INC

Filed

November 15, 1999

Period of Report

November 24, 1999

Accession Number

0000891554-99-002164

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →